Clinical Trials
2
Active:0
Completed:0
Trial Phases
2 Phases
Phase 4:1
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
1 (50.0%)Phase 4
1 (50.0%)Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.
Phase 4
Recruiting
- Conditions
- VitrectomyMacular PuckerRetinal Edema
- Interventions
- First Posted Date
- 2020-08-06
- Last Posted Date
- 2023-06-29
- Lead Sponsor
- Kovach Eye Institute
- Target Recruit Count
- 60
- Registration Number
- NCT04501367
- Locations
- 🇺🇸
Kovach Eye Institute, Elmhurst, Illinois, United States
Prospective Evaluation of the Tecnis Symfony Intraocular Lens (IOL)
Not Applicable
- Conditions
- Cataract SenileCataract
- First Posted Date
- 2018-07-06
- Last Posted Date
- 2018-07-06
- Lead Sponsor
- Kovach Eye Institute
- Target Recruit Count
- 200
- Registration Number
- NCT03579368
News
No news found